Multicenter Phase II Trial of Gefitinib (Iressa) First Line Therapy Followed by Chemotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Gefitinib (Primary) ; Cisplatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 02 Nov 2005 New trial record.